Back to Search
MAHESH PANT, M.D.
M.D.
Radiation Oncology Physician
NPI: 1609875756IndividualAccepts Medicare
Specialties, Licenses & Credentials
Radiation Oncology PhysicianPrimary
Radiology — Radiation Oncology
Code: 2085R0001X
A72603(CA)
CMS Specialties
PrimaryRADIATION ONCOLOGY
Education
UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE
Class of 1996
Research & Publications (20)
Mechanisms of suppression of neoplastic transformation in vitro by low doses of low LET radiation.
PMID 14514653·Carcinogenesis·2003
8-other
Polymorphism in cytochrome P4501A1 is significantly associated with head and neck cancer risk.
PMID 19639480·Cancer Invest·2009
8-other
Evidence for increased cytochrome P450 1A1 expression in blood lymphocytes of lung cancer patients.
PMID 19632247·Mutat Res·2009
8-other
Oral mucositis in morning vs. evening irradiated patients: a randomised prospective study.
PMID 19412843·Int J Radiat Biol·2009
2-rct
Polymorphism in cytochrome P450 2A6 and glutathione S-transferase P1 modifies head and neck cancer risk and treatment outcome.
PMID 19406142·Mutat Res·2009
4-observational
Cytochrome P450 2E1 and head and neck cancer: interaction with genetic and environmental risk factors.
PMID 19334053·Environ Mol Mutagen·2009
8-other
A prospective comparision of sequential chemoradiation vs concurrent chemoradiation in locally advanced oropharyngeal carcinomas.
PMID 19276670·Cancer Biol Ther·2009
4-observational
Comparitive study of efficacy, tolerability of four field box technique vs. two field anterior posterior technique in locally advanced carcinoma cervix--a prospective analysis.
PMID 19270510·Cancer Biol Ther·2009
4-observational
Role of recombinant human erythropoietin in patients of advanced cervical cancer treated "by chemoradiotherapy".
PMID 18981719·Cancer Biol Ther·2009
2-rct
Association of poor metabolizers of cytochrome P450 2C19 with head and neck cancer and poor treatment response.
PMID 18644391·Mutat Res·2008
8-other
Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.
PMID 18573508·Mutat Res·2008
4-observational
Interaction of cytochrome P4501A1 genotypes with other risk factors and susceptibility to lung cancer.
PMID 18082227·Mutat Res·2008
8-other
Genetic polymorphisms in cytochrome P4501B1 and susceptibility to head and neck cancer.
PMID 18067928·Mutat Res·2008
8-other
Association of genetic polymorphisms in glutathione S-transferases and susceptibility to head and neck cancer.
PMID 18035380·Mutat Res·2008
8-other
Hypertension in Delhi: prevalence, awareness, treatment and control.
PMID 17716496·Trop Doct·2007
8-other
Esthesioneuroblastoma treated with non-craniofacial resection surgery followed by combined chemotherapy and radiotherapy: An alternative approach in limited resources.
PMID 16926225·Jpn J Clin Oncol·2006
8-other
Analysis of prognostic variables among patients with locally advanced head and neck cancer treated with late chemo-intensification protocol: impact of nodal density and total tumor volume.
PMID 16905755·Jpn J Clin Oncol·2006
8-other
Late chemo-intensification with cisplatin and 5-fluorouracil as an adjunct to radiotherapy: a pragmatic approach for locally advanced head and neck squamous cell carcinoma.
PMID 16480913·Oral Oncol·2006
3-trial
GSTT1, GSTM1 and GSTP1 genetic polymorphisms and interaction with tobacco, alcohol and occupational exposure in esophageal cancer patients from North India.
PMID 16338071·Cancer Lett·2006
8-other
Mitomycin and fluorouracil in combination with concomitant radiotherapy: a potentially curable approach for locally advanced head and neck squamous cell carcinoma.
PMID 16186175·Jpn J Clin Oncol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 963 BUTTE ST
REDDING, CA 96001 - Phone
- (530) 245-5900
Quick Facts
- NPI
- 1609875756
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 30
- Publications
- 20
Are you this provider?
Claim Your Profile